Impaired T cell proliferation and zeta chain phosphorylation after stimulation with staphylococcal enterotoxin-B in hemodialysis patients

Nephron - Clinical Practice

Volumn 96, Issue 1, 2004, Pages

  Eleftheriadis, Theodoros ^a,d   Papazisis, Konstantinos ^b   Kortsaris, Alexandros ^c   Vayonas, Georgios ^a   Voyatzi, Sultana ^b   Vargemezis, Vasilios ^c  

^a Department of Nephrology   (Greece)

^b Department of Pathology   (Greece)

^c DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^d NONE   (Greece)

Author keywords

Hemodialysis; Immunodeficiency; Staphylococcus enterotoxin; T cell; Zeta chain

Indexed keywords

ANTIBODY; BROXURIDINE; PHOSPHOTYROSINE ANTIBODY; STAPHYLOCOCCUS ENTEROTOXIN B; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL CULTURE; CELL ISOLATION; CELL PROLIFERATION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MALE; MONONUCLEAR CELL; PHOSPHORYLATION; PRIORITY JOURNAL; STAPHYLOCOCCUS; T LYMPHOCYTE;

ADULT; AGED; CASE-CONTROL STUDIES; CELL DIVISION; CELLS, CULTURED; ENTEROTOXINS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PHOSPHORYLATION; RECEPTORS, ANTIGEN, T-CELL; RENAL DIALYSIS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 1842579524     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000075567     Document Type: Article

References (49)

1. Sarnak M, Jaber B: Mortality caused by sepsis in patients with end-stage renal disease compared with the normal population. Kidney Int 2000;58:1758-1764.
2. Descamps-Latscha B, Jungers P: Immunological and chronic inflammatory abnormalities in end-stage renal disease, chap 45; in Jacobs C, Kjellstrand CM, Koch KM, Winchester JF (eds): Replacement of Renal Failure by Dialysis, ed 4. Dordrecht, Kluwer Academic Publishers, 1996, pp 1083-1102.
3. Beaman M, Michael J, MacLennan ICM, Adu D: T-cell-independent and T-cell-dependent antibody responses in patients with chronic renal failure. Nephrol Dial Transplant 1989;4:216-221.
4. Rangel M, Coronado V, Euler G, Strikas R: Vaccine recommendations for patients on chronic dialysis. Semin Dial 2000;13:101-107.
5. Girndt M, Sester U, Sester M, Kaul H, Köhler H: Impaired cellular immune function in patients with chronic renal failure. Nephrol Dial Transplant 1999;14:2807-2810.
6. Sester U, Hauk M, Kaul H, Köhler H, Girndt M: T cell activation follows Th1 rather than Th2 pattern in haemodialysis patients. Nephrol Dial Transplant 2000;15:1217-1223.
7. Girndt M, Heisel O, Kohler H: Influence of dialysis with polyamide vs. haemophan haemodialysers on monokines and complement activation during a 4-month long term study. Nephrol Dial Transplant 1999;14:676-682.
8. Tzano-Martins C, Futana E, Jorgett V, Duarte AJS: Restoration of impaired T-cell proliferation after parathyroidectomy in hemodialysis patients. Nephron 2000;84:224-227.
9. Moe S, Zekonis M, Harezlak J, Ambrosius W, Gassensmith C, Marphy C, Russel R, Butnik D: A placebo-controlled trial to evaluate immunomodulatory effects of paricalcitol. Am J Kidney Dis 2001;3:792-802.
10. 2+] and proliferation of B-lymphocytes on dialysis patients. Am J Kidney Dis 1997;29:233-238.
11. Birmingham D, Shen XP, Hartman J, Dillon J, Hebert L: Effect of chronic human recombinant erythropoietin therapy on antibody responses to immunization in chronic dialysis patients. Kidney Int 1996;50:543-549.
12. Keown P, Descamps-Latscha B: In vitro suppression of cell-mediated immunity by ferroproteins and ferric salts. Cell Immunol 1983;80:257-266.
13. Bender BS, Curtis JL, Nagel JE: Analysis of immune status of hemodialysed adults: Association with prior transfusions. Kidney Int 1984;26:436-441.
14. Fields BA, Malchiodi EL, Ysern X: Crystal structure of a T cell receptor β chain complexed with a superantigen. Nature 1996;383:188-192.
15. Gascoigne N, Ames K: Direct binding of secreted T-cell receptor β chain to superantigen associated with class II major histocompatibility complex protein. Proc Natl Acad Sci USA 1991;88:613-616.
16. Oyaizu N, Chirmule N, Yagura H, Pahwa R, Good R, Pahwa S: Superantigen staphylococcal enterotoxin B-induced T-helper cell activation is independent of CD4 molecules and phosphatidylinositol hydrolysis. Proc Natl Acad Sci USA 1992;89:8035-8039.
17. Reinherz EL, Tan K, Tang L, Kern P, Liu J, Xiong Y, Hussey RE, Smolyar A, Hare B, Zhang R, Joachimiak A, Chang HC, Wagner G, Wang J: The crystal structure of a T cell receptor in complex with peptide and MHC class II. Science 1999;286:1913-1921.
18. Lenschow D, Walunas T, Blueston J: CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996;14:233-258.
19. Mittrucker HW, Shahinian A, Bouchard D, et al: Induction of unresponsiveness and impaired T-cell expansion by staphylococcal enterotoxin B in CD28-deficient mice. J Exp Med 1996;183:2481-2488.
20. Krummel MF, Sullivan TJ, Allison JP: Superantigen responses and co-stimulation: CD28 and CTLA-4 have opposing effects on T cell expansion in vitro and in vivo. Int Immunol 1996;8:519-523.
21. Watts C: Capture and processing of exogenous antigens for presentation on MHC molecules. Annu Rev Immunol 1997;15:821-850.
22. Robertson M: Antigen presentation. Curr Biol 1998;8:821-829.
23. Davis MM, Bjorkman PJ: T-cell receptor antigen genes and T-cell recognition. Nature 1998;334:395-402.
24. Abbas A, Lichtman A, Pober J: Box 15-1 in Immunity to microbes, chap 15; in Abul A, Lichtman A, Pober J (eds): Cellular and Molecular Immunology, ed 4. Philadelphia, Saunders, 2000, p 347.
25. Hayward AR, Herberger M: Lymphocyte response to varicella zoster virus in the elderly. J Clin Immunol 1987;7:174-178.
26. Janeway C, Travers P, Walport M, Schlomchic M: Signaling through immune system receptors, chap 6; in Janeway C, Travers P, Walport M, Schlomchic M (eds): Immunobiology: The Immune System in Health and Disease, ed 5. Edinburgh, Churchill-Livingstone, 2001, pp 186-220.
27. Germain R, Stefanova I: The dynamics of T-cell receptor signaling: Complex orchestration and the key roles of tempo and cooperation. Annu Rev Immunol 1999;17:467-522.
28. Niedergang F, Daurty-Varsat A, Alcover A: Cooperative activation of TCRs by enterotoxin superantigen. J Immunol 1998;161:6054-6058.
29. Yamasaki S, Tachibana M, Shinohara N, Iwashima M: Lck-independent triggering of T-cell antigen receptor signal transduction by staphylococcal enterotoxins. J Biol Chem 1997;272:14787-14791.
30. Bandley GA, Mariuzza RA: The structure of the T-cell antigen receptor. Annu Rev Immunol 1996;14:563-590.
31. Bolliger L and Johansson B: Identification and functional characterization of the ζ-chain dimerization motif for TCR expression. J Immunol 1999;163:3867-3876.
32. Hemmer B, Stefanova I, Vergelli M, Germain N, Martin R: Relationships among TCR ligand potency, thresholds, for effector function elicitation, and quality of early signaling events in human T cells. J Immunol 1998;160:5807-5814.
33. Irring BA, Chan AC, Weiss A: Functional characterization of a signal transducing motif present in the T cell receptor ζ chain. J Exp Med 1993;177:1093-1103.
34. Denny M, Patai B, Straus D: Differential T-cell antigen receptor signaling mediated by the src family kinases Lck and Fyn. Mol Cel Biol 2000;20:1426-1435.
35. Koople J, Wolfson M, Chertow G, Salusky I: Guideline 3: Serum albumin is a valid and clinically useful measure of protein-energy nutritional status in maintenance dialysis. Am J Kidney Dis 2000;35(suppl 2):S20-S21.
36. Koople J, Wolfson M, Chertow G, Salusky I: Guideline 10: Anthropometry: Anthropometric measurements are valid and clinically useful indicators of protein-energy nutritional status in maintenance dialysis patients. Am J Kidney Dis 2000;35(suppl 2):S32-S33.
37. Jacobs C, Horl W, Mcdougal I, Valderrano F, Parrondo I, Abraham L, Cremers S: European best practice guidelines 9-13: Anaemia management. Nephrol Dial Tranplant 2000;15(suppl 4):S33-S42.
38. Cannata-Andia J, Drueke TB: Clinical algorithms on renal osteodystrophy. Nephrol Dial Transplant 2000;13(suppl 5):S39-S57.
39. Shaefer RM, Shaefer L: Iron monitoring and supplementation: how do we achieve the best results? Nephrol Dial Transplant 1998;13(suppl 2):9-12.
40. Magaud JP, Sargent I, Mason DY: Detection of human white cell proliferation responses by immunoenzymatic measurement of bromodeoxyuridine uptake. J Immunol Methods 1998;106:95-100.
41. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein. Anal Biochem 1976;72:248-254.
42. Beaurain G, Naret C, Marcon L, Grateau G, Drueke t, Urena P, Nelson DL, Bach JF, Chatenoud L: In vivo T-cell preactivation in chronic uremia hemodialyzed and non-hemodialyzed patients. Kidney Int 1989;36:636-644
43. Kanner SB, Odum N, Grosmaire L, Masewicsz S, Svejgaard A, Ledbetter JA: Superantigen and HLA-DR ligation induce phospholipase-C gamma 1 activation in class II+ T cells. J Immunol 1992;149:3482-3488.
44. Stachowski J, Pollok M, Burrichter H, Spithaler C,Baldamus CA: Signalling via the TCR/CD3 antigen receptor complex is limited by receptors number. Nephron 1993;64:369-375.
45. Stachowski J, Pollok M, Burth C Maciejewski J, Baldamus CA: Non-responsiveness to hepatitis B vaccination in haemodialysis patients: Association with impaired TCR/CD3 antigen receptor expression co-stimulatory processes in antigen presentation and recognition. Nephrol Dial Transplant 1994;9:144-152.
46. Demotz S, Grey HM, SetteA: The minimal number of class II MHC-antigen complexes needed for T-cell activation. Science 1990;249:1028-1030.
47. Christinck ER, Luscher MA, Barber BH, Williams DB: Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis. Nature 1991;352:67-70.
48. Grakoni A, Bromley S, Sumen C, Davis M, Shaw S, Allen P, Dustin M: The immunological synapse: A molecular machine controlling T-cell activation. Science 1999;285:221-227.
49. Thomas LM: The regulation of antigen-receptor signaling by protein tyrosine phosphatases: A hole in a story. Curr Opin Immunol 1999;11:270-276.